Abstract
5th International Hospital Diabetes Meeting
AGENDA Friday, May 8, 2015
08:00
David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE Mills-Peninsula Health Services, San Mateo, California
08:02
Guillermo Umpierrez, MD Emory University, Atlanta, Georgia
Keynote Address
08:05
Erin S. DuPree, MD, FACOG Joint Commission Center for Transforming Healthcare Oakbrook Terrace, Illinois
Session 1: Measuring Glucose in Hospitalized and Critically Ill Patients
08:35
Greg Maynard, MD, MSc, SFHM UC Davis, Sacramento, California
08:55
Gerry Rayman, MD, FRCP Ipswich Hospital Diabetes Center, Ipswich, United Kingdom
09:15
Mitchell G. Scott, PhD, DABCC Washington University, St. Louis, Missouri
09:45
David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE Mills-Peninsula Health Services, San Mateo, California
09:55
10:15
Session 2: Glycemic Targets in Various Settings
10:40
Stanley A. Nasraway, MD Tufts Medical Center, Boston, Massachusetts
11:00
Garry S. Tobin, MD Washington University, St. Louis, Missouri
11:20
Darrell M. Wilson, MD Stanford University, Stanford, California
11:40
Amisha Wallia, MD, MS Northwestern Medical Group, Chicago, Illinois
12:00
12:20
Sharon Geaghan, MD Stanford University, Stanford, California
Christel Marchand Aprigliano, BA, MSc StripSafely, Tampa, Florida
13:20
Session 3: Technology
13:50
Mitchell G. Scott, PhD, DABCC Washington University, St. Louis, Missouri
14:10
Stanley A. Nasraway, MD Tufts Medical Center, Boston, Massachusetts
14:30
Guillermo Umpierrez, MD Emory University, Atlanta, Georgia
14:50
Alberto Gutierrez, PhD
U.S. Food and Drug Administration, Silver Spring, Maryland
15:10
15:30
Session 4: Glucose Management Teams
15:55
Jane Jeffrie Seley, DNP, MPH, BC-ADM, CDE, CDTC New York-Presbyterian/Weill Cornell, New York, New York
16:15
Curtiss B. Cook, MD Mayo Clinic, Scottsdale, Arizona
16:35
Robert J. Rushakoff, MD UC San Francisco, San Francisco, California
16:55
17:10
AGENDA Saturday, May 9, 2015
08:00
David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE Mills-Peninsula Health Services, San Mateo, California
Session 5: Insulin Dosing and Safety
08:05
Greg Maynard, MD, MSc, SFHM UC Davis, Sacramento, California
08:25
Thomas Pieber, MD Medical University of Graz, Graz, Austria
08:45
Jane Jeffrie Seley, DNP, MPH, BC-ADM, CDE, CDTC New York-Presbyterian/Weill Cornell, New York, New York
09:05
Robert J. Rushakoff, MD UC San Francisco, San Francisco, California
09:25
09:50
Session 6: Hypoglycemia
10:15
Thomas Pieber, MD Medical University of Graz, Graz, Austria
10:35
Garry S. Tobin, MD Washington University, St. Louis, Missouri
10:55
Mikhail Kosiborod, MD Saint Luke’s Mid America Heart Institute Kansas City, Missouri
11:15
Robert A. Vigersky, MD Medical Director, Medical Affairs, Medtronic Diabetes
Professor of Medicine Uniformed Services University of the Health Sciences
Director Emeritus Diabetes Institute Walter Reed National Military Medical Center
11:35
12:00
Session 7: Special Populations
13:00
Boris Draznin, MD, PhD University of Colorado, Aurora, Colorado
13:20
Mark J. Rice, MD Vanderbilt University, Nashville, Tennessee
13:40
Amisha Wallia, MD, MS Northwestern Medical Group, Chicago, Illinois
14:00
Gerry Rayman, MD, FRCP Ipswich Hospital Diabetes Center, Ipswich, United Kingdom
14:20
14:45
Session 8: Novel Therapeutics
15:10
Robert A. Vigersky, MD Medical Director, Medical Affairs, Medtronic Diabetes
Professor of Medicine Uniformed Services University of the Health Sciences
Director Emeritus Diabetes Institute Walter Reed National Military Medical Center
15:35
Curtiss B. Cook, MD Mayo Clinic, Scottsdale, Arizona
16:00
Mikhail Kosiborod, MD Saint Luke’s Mid America Heart Institute Kansas City, Missouri
16:25
16:50
Robert A. Vigersky, MD Medical Director, Medical Affairs, Medtronic Diabetes
Professor of Medicine Uniformed Services University of the Health Sciences
Director Emeritus Diabetes Institute Walter Reed National Military Medical Center
17:00